GE HealthCare Technologies Inc. $GEHC Position Reduced by Skandinaviska Enskilda Banken AB publ

Skandinaviska Enskilda Banken AB publ reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 90,129 shares of the company’s stock after selling 11,304 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in GE HealthCare Technologies were worth $6,766,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Godsey & Gibb Inc. bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. E Fund Management Hong Kong Co. Ltd. boosted its holdings in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after acquiring an additional 196 shares in the last quarter. Allianz SE grew its holdings in GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after acquiring an additional 218 shares during the period. Oakworth Capital Inc. lifted its stake in GE HealthCare Technologies by 1,876.2% during the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after purchasing an additional 394 shares during the last quarter. Finally, Piscataqua Savings Bank lifted its position in shares of GE HealthCare Technologies by 173.4% during the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after acquiring an additional 300 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Up 0.1%

NASDAQ:GEHC opened at $83.01 on Friday. The stock’s 50 day moving average price is $82.26 and its 200 day moving average price is $77.88. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $93.14. The company has a market capitalization of $37.83 billion, a P/E ratio of 18.20, a P/E/G ratio of 1.83 and a beta of 1.08. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.07%.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of analyst reports. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Jefferies Financial Group lifted their target price on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Stifel Nicolaus lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Bank of America raised their target price on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research report on Monday, January 5th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $92.50.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.